Zogenix, Inc.
ZGNXDelisted Mar 7, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001375151
Zogenix, Inc. was delisted on Mar 7, 2022; its insiders filed their last Form 4 on Mar 9, 2022; 156 institutions reported holding it in 13F filings for Q4 2021, worth $968.4M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Zogenix, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Zogenix, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Garner Cam L | Director | 0Indirect | Mar 9, 2022 | 0 |
| Mast Erle T | Director | 0 | Mar 9, 2022 | 0 |
| Wiggins Mark C | Director | 0 | Mar 9, 2022 | 0 |
| Breitmeyer James B | Director | 0 | Mar 9, 2022 | 0 |
| Farr Stephen J | President & CEO | 0 | Mar 9, 2022 | 0 |
| Bock Louis C | Director | – | Mar 9, 2022 | 0 |
| Smith Michael P | EVP, CFO & Treasurer | 0 | Mar 9, 2022 | 0 |
| Loewy Caroline M | Director | – | Mar 9, 2022 | 0 |
| Tannenbaum Renee P | Director | 0 | Mar 9, 2022 | 0 |
| Galer Bradley S. | EVP & Chief Medical Officer | 0 | Mar 9, 2022 | 0 |
| Farfel Gail M | See Remarks | 0 | Mar 9, 2022 | 0 |
| Sagrolikar Ashish M | EVP & Chief Operating Officer | 0 | Mar 9, 2022 | 0 |
| Mitchell Shawnte | EVP, GC & Secretary | 0 | Mar 9, 2022 | 0 |
| Waynick Denelle J | Director | 0 | Mar 9, 2022 | 0 |
| Stutts Mary E. | Director | – | Mar 9, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2022 (view filing) | Feb 1 | 2 days | Mast Erle TDirector | SSale | −1.25K | $26.04 | −$32.5K | −29.2%3.03K after | |
| Jan 21, 2022 (view filing) | Jan 19 | 2 days | Mast Erle TDirector | SSaleStock Option (Right to Buy) | −15.0K | $26.09 | −$391.4K | −83.2%3.03K after | |
| Nov 30, 2021 (view filing) | Nov 29 | 1 day | Tannenbaum Renee PDirector | SSale | −5.30K | $11.72 | −$62.2K | −14.0%32.6K after | |
| Aug 12, 2021 (view filing) | Aug 10 | 2 days | Garner Cam LDirector | PPurchase | +10.0K | $14.83 | +$148.3K | +32.3%41.0K after |